Добавить новость
ru24.net
News in English
Май
2019

GSK's Shingrix skyrockets toward the £1B mark as HIV drugs falter

0
GlaxoSmithKline’s shingles vaccine Shingrix is growing insanely fast. So fast, in fact, it's on track to surpass £1 billion in sales for its second full year on the market. But another pillar of the British drugmaker’s business—its HIV franchise—is suffering from new competition.



Moscow.media
Частные объявления сегодня





Rss.plus
















Музыкальные новости




























Спорт в России и мире

Новости спорта


Новости тенниса